← Back
$LGND All transactions

LIGAND PHARMACEUTICALS INC

A

$ Value

$0

Shares

1,209

Price

$0

Filed

Jun 10

Insider

Name

LAMATTINA JOHN L

Title

CIK

0001216074

Roles

Director

Transaction Details

Transaction Date

2025-06-06

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

30,724

Footnotes

Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 6, 2025. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. | Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 6, 2025. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Filing Info

Accession No.

0002001011-25-000044

Form Type

4

Issuer CIK

0000886163

LAMATTINA JOHN L's History

Date Ticker Type Value
2026-03-06 LGND M $247K
2026-03-06 LGND $434K
2026-03-06 LGND M $0
2025-11-07 LGND M $142K
2025-11-07 LGND $441K
2025-11-07 LGND M $141K
2025-11-07 LGND $418K
2025-11-07 LGND M $0
2025-11-07 LGND M $0
2025-06-06 LGND A $0

Other Insiders at LGND (90d)

Insider Bought Sold Last
LAMATTINA JOHN L $434K 2026-03-06
KOZARICH JOHN W $94K 2026-04-01
Davis Todd C
Chief Executive Officer
2026-03-02
Sabba Stephen L $208K 2026-03-23
Espinoza Octavio
Chief Financial Officer
2026-03-02
Reardon Andrew
CLO & Secretary
$1.0M 2026-04-01